Numerus
Private Company
Funding information not available
Overview
Numerus is a specialized biostatistics services firm based in Cambridge, UK, that supports life sciences companies from clinical development through market access. The company leverages a team with deep collective industry experience to offer statistical design, analysis, and reporting for clinical trials, HTA submissions, and real-world data studies. It operates as a service provider rather than a drug developer, helping clients build compelling evidence narratives for regulators and payers. Numerus addresses the critical need for robust statistical evidence in an increasingly complex and data-driven regulatory environment.
Technology Platform
Expert biostatistical consultancy leveraging advanced statistical methodologies (e.g., clinical trial simulation, evidence synthesis, real-world data analysis) within a regulatory framework, utilizing tools like SAS and R.
Opportunities
Risk Factors
Competitive Landscape
Numerus competes in a fragmented market including large full-service Contract Research Organizations (CROs) with biostatistics divisions and other specialized statistical consultancies. Its differentiation is based on high-touch, expert-level service and deep regulatory experience, rather than scale or low cost.